Jens Eichhorn, MD
banner
jenseichhornmd.bsky.social
Jens Eichhorn, MD
@jenseichhornmd.bsky.social
Cardiologist at Sanger Heart & Vascular Institute at @wakeforestmed in Charlotte, NC. General Cardiology and Multimodality imaging #YesCTSky #EchoFirstSky #VascularSky #CardioSky #MedSky
🚀🏔️🏃‍♂️ Fantastic #Gardin lecture at #ASE2025! Chaired by Dr. Dermot Phelan Dr. Benjamin Levine showed how echo—from endurance athletes to astronauts—reveals how exercise preserves compliance, prevents diastolic dysfunction, slows cardiovascular aging, echoing the impact of Dr. Gardin’s contributions.
September 5, 2025 at 8:06 PM
Reposted by Jens Eichhorn, MD
We are proud to present our ASE Timeline Wall, showcasing all of ASE’s presidents and important milestones over the last 50 years! 🫀

You can find the ASE Timeline Wall to the right of our registration booth. #ASE2025 #ASE50th
September 5, 2025 at 2:22 PM
Reposted by Jens Eichhorn, MD
🫀NEW GUIDELINE🫀
Read our newest #ASEGuideline, "Clinical Applications of Strain Echocardiography," developed in collaboration with the European Association of Cardiovascular Imaging of the European Society of Cardiology! bit.ly/4lUOQcM #CardioSky
Clinical Applications of Strain Echocardiography (Article In Press) – ASE
Clinical Applications of Strain Echocardiography: A Clinical Consensus Statement From the American Society of Echocardiography Developed in Collaboration With the European Association of Cardiovascula...
bit.ly
September 3, 2025 at 1:50 PM
Reposted by Jens Eichhorn, MD
We’re at the Music City Center in downtown Nashville and SO excited for our #ASE2025 Scientific Sessions to begin this Friday! 🫀 #ASE50th
September 4, 2025 at 9:19 PM
Reposted by Jens Eichhorn, MD
We have an entire Microlesson Series on HCM, comprised of 15 videos that dive into all things #HCM! 🫀

The best part: they are #FREE.

Earn 2 AMA PRA Category 1 Credit(s)™ by enrolling in our "Hypertrophic Cardiomyopathy Microlessons: On-Demand!" bit.ly/3AbtOEB
August 6, 2025 at 12:21 PM
Reposted by Jens Eichhorn, MD
President Maros Ferencik spoke with
@auntminnie.bsky.social
about #SCCT2025 and shared some highlights & trends that attendees can expect to absorb in Montréal this week. Watch the video:
www.auntminnie.com/clinical-new...
Video: SCCT president offers highlights for upcoming meeting
SCCT President Maros Ferencik, MD, PhD, spoke to AuntMinnie about research and trends that will be explored at the society's upcoming meeting.
www.auntminnie.com
July 17, 2025 at 6:08 PM
Reposted by Jens Eichhorn, MD
Thrilled to announce publication of our paper: Myeloid-Specific JAK2 Contributes to Inflammation & Salt Sensitivity of Blood Pressure” in CircRes!
@ahascience.bsky.social

ahajournals.org/doi/10.1161/CIRCRESEARCH.PAPER

#Hypertension #Inflammation #ScienceImpact
November 16, 2024 at 3:48 AM
Reposted by Jens Eichhorn, MD
Dr Ouzounian reviews sex based differences in aortic disease in women. Lower prevalence of an aneurysms disease but worse outcomes with aneurysm and dissection #AHA24 #Cardiosky
November 17, 2024 at 4:14 PM
Reposted by Jens Eichhorn, MD
Sitting down with APAC Pres Laura Ross and summing up my presentations at #CAPPLive 24'

1) Understand LDL-C goals and why!
2) There are non-statin lipid lowering therapies
3) Yes, you can/should use statins in those w/Liver Dz - up til' decomp cirrhosis ;)
#AHA24

youtu.be/84TOeVlEyho?...
The APAC Recap: Dyslipidemia at CAPP Live 2024 with Viet Le, DMSc, PA-C
YouTube video by HCPLive
youtu.be
November 17, 2024 at 12:45 PM
Reposted by Jens Eichhorn, MD
#LBCT #SUMMIT trial #AHA24
💥 Treatment with tirzepatide led to ⤵️risk of a composite of death from cardiovascular 🫀 causes or worsening heart failure 🆚 placebo and improved health status in patients with HFpEF+obesity
📎 @NEJM www.nejm.org/doi/full/10....
November 16, 2024 at 3:16 PM
Reposted by Jens Eichhorn, MD
November 16, 2024 at 4:46 PM
Reposted by Jens Eichhorn, MD
So exciting! #SUMMIT trial, the first #HFpEF trial of incretin therapy with HF clinical outcomes as prespecified primary outcome. And #tirzepatide reduced CV death or worsening HF by significant 38%! Improvement in KCCQ quality of life by 7 pts, wt loss 12%, hsCRP reduction by 35%! #AHA24 #CardioSky
November 16, 2024 at 3:19 PM